Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis
- PMID: 19517202
- PMCID: PMC2772938
- DOI: 10.1007/s11999-009-0924-5
Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis
Abstract
Heterotopic ossification (HO) is a potentially severe, if infrequent, complication in hip surgery, and uncertainty exists regarding whether to use NSAIDs or radiation in its prevention. Thus, we systematically reviewed the literature in MedLine, EMBASE, CINAHL, and the Cochrane Controlled Trial Register and, after ruling out publication bias and data heterogeneity, performed a meta-analysis of randomized, controlled trials to assess effectiveness and complications of NSAIDs and radiation in the prevention of HO. We identified nine studies reporting on effectiveness and complications including a total of 1295 patients. The pooled risk ratio for the effectiveness in HO prevention was 0.96 (95% confidence interval, 0.88-1.06) and was independent of the type of surgery (THA or open reduction and internal fixation). There was no association with gender, age, length of followup, or year of publication. The risk ratio for associated complications was 0.79 (95% confidence interval, 0.45-1.41), and, again, was independent of the aforementioned factors. We found no evidence for a statistically significant or clinically important difference between NSAIDs or radiation in preventing HO.
Figures



References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1111/j.1445-2197.2007.04178.x', 'is_inner': False, 'url': 'https://doi.org/10.1111/j.1445-2197.2007.04178.x'}, {'type': 'PubMed', 'value': '17635276', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17635276/'}]}
- Back DL, Smith JD, Dalziel RE, Young DA, Shimmin A. Incidence of heterotopic ossification after hip resurfacing. ANZ J Surg. 2007;77:642–647. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1136/bmj.38960.600822.80', 'is_inner': False, 'url': 'https://doi.org/10.1136/bmj.38960.600822.80'}, {'type': 'PMC', 'value': 'PMC1562461', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1562461/'}, {'type': 'PubMed', 'value': '16960187', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16960187/'}]}
- Birrell F, Lohmander S. Non-steroidal anti-inflammatory drugs after hip replacement. BMJ. 2006;333:507–508. - PMC - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1302/0301-620X.89B4.18845', 'is_inner': False, 'url': 'https://doi.org/10.1302/0301-620x.89b4.18845'}, {'type': 'PubMed', 'value': '17463108', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17463108/'}]}
- Board TN, Karva A, Board RE, Gambhir AK, Porter ML. The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty. J Bone Joint Surg Br. 2007;89:434–440. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1055/s-2008-1039411', 'is_inner': False, 'url': 'https://doi.org/10.1055/s-2008-1039411'}, {'type': 'PubMed', 'value': '9446435', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9446435/'}]}
- Bremen-Kühne R, Stock D, Franke C. [Indomethacin: short-term therapy vs. single low dosage radiation for prevention of periarticular ossifications after total hip endoprosthesis] [in German]. Z Orthop Ihre Grenzgeb. 1997;135:422–429. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '11741055', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11741055/'}]}
- Burd T, Lowry K, Anglen J. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. J Bone Joint Surg Am. 2001;83:1783–1788. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources